Your browser doesn't support javascript.
Reflections on development of rapid and living evidence-based Chinese medicine guidelines for Coronavirus disease 2019
Chinese Journal of Integrated Traditional and Western Medicine ; 42(2):218-222, 2022.
Article in Chinese, English | CAB Abstracts | ID: covidwho-1837498
ABSTRACT
As evidence is rapidly accumulated and updated during the coronavirus disease 2019 (COVID-19) pandemic, rapid and living guidelines are needed to guide the clinical practice of Chinese medicine (CM), for which the WHO handbook of rapid guideline development should be referred to, and the characteristics of CM should be addressed. When constructing the body of evidence, we need to systematically search the studies related to COVID-19 (direct) and indirect diseases, and to collect the experience evidence from ancient documents and expert consensus, thereby maximumly presenting the advantages of CM. When the recommendations are developed, the co-existing direct and indirect evidence, as well as the co-existing research and experience evidence should be fully considered and synthesized by taking priority on whichever higher level evidence it is. The development of the rapid and living CM guidelines meets the ever-changing clinical needs during COVID-19 pandemic, and can provide CM evidence supports for decision making during public health emergencies.
Keywords
Search on Google
Collection: Databases of international organizations Database: CAB Abstracts Topics: Traditional medicine Language: English / Chinese Journal: Chinese Journal of Integrated Traditional and Western Medicine Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS

Search on Google
Collection: Databases of international organizations Database: CAB Abstracts Topics: Traditional medicine Language: English / Chinese Journal: Chinese Journal of Integrated Traditional and Western Medicine Year: 2022 Document Type: Article